Home » Market News » DirectorsTalk Highlights » Here’s Everything You Need to Know About Coronavirus and Immune Deficiencies
Immupharma Plc

Here’s Everything You Need to Know About Coronavirus and Immune Deficiencies

Experts say that people with chronic conditions that affect the immune system, such as lupus and diabetes, are at a higher risk of developing severe complications from coronavirus. Here’s what you need to know about immunocompromised patients and coronavirus COVID-19.

In light of a flu season that has unofficially become “flu-and-coronavirus season”, there’s a lot of buzz around those who are most at risk for severe complications from coronaviruses: specifically, the elderly and those who are immunocompromised. But what does it actually mean to be immunocompromised? And how does having a compromised immune system play out with coronavirus COVID-19? Here, experts explain everything you need to know about protecting people with immune deficiencies amid the coronavirus outbreak.

Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.